These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31625164)

  • 1. T cell addiction: can pathogenic T cells be controlled using dopamine receptors?
    Bain KA; Milling S
    Immunology; 2019 Nov; 158(3):151-152. PubMed ID: 31625164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunoregulatory role of dopamine: an update.
    Sarkar C; Basu B; Chakroborty D; Dasgupta PS; Basu S
    Brain Behav Immun; 2010 May; 24(4):525-8. PubMed ID: 19896530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Instantaneous depolarization of T cells via dopamine receptors, and inhibition of activated T cells of Psoriasis patients and inflamed human skin, by D1-like receptor agonist: Fenoldopam.
    Keren A; Gilhar A; Ullmann Y; Zlotkin-Frušić M; Soroka Y; Domb AJ; Levite M
    Immunology; 2019 Nov; 158(3):171-193. PubMed ID: 31424569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Dopaminergic System in Autoimmunity.
    Vidal PM; Pacheco R
    J Neuroimmune Pharmacol; 2020 Mar; 15(1):57-73. PubMed ID: 30661214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Close encounters of the monoamine kind: immune cells betray their nervous disposition.
    Meredith EJ; Chamba A; Holder MJ; Barnes NM; Gordon J
    Immunology; 2005 Jul; 115(3):289-95. PubMed ID: 15946246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic Pathways in Obesity-Associated Inflammation.
    Leite F; Ribeiro L
    J Neuroimmune Pharmacol; 2020 Mar; 15(1):93-113. PubMed ID: 31317376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine, Immunity, and Disease.
    Channer B; Matt SM; Nickoloff-Bybel EA; Pappa V; Agarwal Y; Wickman J; Gaskill PJ
    Pharmacol Rev; 2023 Jan; 75(1):62-158. PubMed ID: 36757901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function.
    Huang Y; Qiu AW; Peng YP; Liu Y; Huang HW; Qiu YH
    Neuro Endocrinol Lett; 2010; 31(6):782-91. PubMed ID: 21196914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic regulation of immune cells via D3 dopamine receptor: a pathway mediated by activated T cells.
    Ilani T; Strous RD; Fuchs S
    FASEB J; 2004 Oct; 18(13):1600-2. PubMed ID: 15319371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autonomic regulation of T-lymphocytes: Implications in cardiovascular disease.
    Elkhatib SK; Case AJ
    Pharmacol Res; 2019 Aug; 146():104293. PubMed ID: 31176794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.
    Matt SM; Gaskill PJ
    J Neuroimmune Pharmacol; 2020 Mar; 15(1):114-164. PubMed ID: 31077015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine exerts no acute effects on Kv1.3 in activated encephalitogenic T cells.
    Strauss U; Herbrik M; Mix E; Bajorat R; Jung S; Gimsa U; Rolfs A
    Neuroimmunomodulation; 2005; 12(1):45-53. PubMed ID: 15756052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the interaction of the dopaminergic and serotoninergic systems in immunomodulation].
    Devoĭno LV; Al'perina EL
    Fiziol Zh SSSR Im I M Sechenova; 1984 Feb; 70(2):239-46. PubMed ID: 6714473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of the immune response during activation of the dopaminergic system in mice with opposite types of behavior.
    Idova GV; Cheido MA; Zhukova EN; Devoino LV
    Neurosci Behav Physiol; 2004 May; 34(4):417-21. PubMed ID: 15341221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of putative dopamine receptors in neurites outgrowing from locust central nervous system explants using anti-idiotypic dopamine antibodies.
    Vanhems E; Delbos M; Geffard M; Viellemaringe J
    Neuroscience; 1994 Feb; 58(3):649-55. PubMed ID: 8170540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging evidence for the role of neurotransmitters in the modulation of T cell responses to cognate ligands.
    Pacheco R; Riquelme E; Kalergis AM
    Cent Nerv Syst Agents Med Chem; 2010 Mar; 10(1):65-83. PubMed ID: 20236043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors.
    Levite M
    Curr Opin Pharmacol; 2008 Aug; 8(4):460-71. PubMed ID: 18579442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine, T cells and multiple sclerosis (MS).
    Levite M; Marino F; Cosentino M
    J Neural Transm (Vienna); 2017 May; 124(5):525-542. PubMed ID: 28283756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The modulatory role of dopamine receptors in brain neuroinflammation.
    Xia QP; Cheng ZY; He L
    Int Immunopharmacol; 2019 Nov; 76():105908. PubMed ID: 31622861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of dopamine receptor gene polymorphisms on circulating T lymphocytes: A pilot study in healthy subjects.
    Cosentino M; Ferrari M; Kustrimovic N; Rasini E; Marino F
    Hum Immunol; 2015 Oct; 76(10):747-52. PubMed ID: 26429319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.